CLINICAL_TRIALS
trial_result
· 2017-12-12
Clinical Trial Update: Add-on Methotrexate for the Treatment of Schizophrenia [Phase 2]
Summary
A Phase 2 trial is evaluating add-on methotrexate for schizophrenia; no clinical results are provided in the update.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sheba Medical Center | Conditions: Schizophrenia | Phase 2 | Status: UNKNOWN